Secondary Antibodies

General description Anti-AKT Antibody detects endogenous levels of total AKT protein. Immunogen The antiserum was produced against synthesized peptide derived from human Akt.

General description Anti-AKT Antibody detects endogenous levels of total AKT protein. Immunogen The antiserum was produced against synthesized peptide derived from human Akt.

General description Anti-AKT2 Antibody detects endogenous levels of total AKT2 protein. Immunogen The antiserum was produced against synthesized peptide derived from human Akt2.

General description Anti-ALDOB Antibody detects endogenous levels of total ALDOB protein. Immunogen The antiserum was produced against synthesized peptide derived from human ALDOB.

Immunogen Peptide with sequence LKACYYQIQREKLN, from the C Terminus of the protein sequence according to NP_065970.2.

Specificity The antibody detects endogenous levels of total ANXA2R protein. Immunogen Synthetic peptide corresponding to residues near the N terminal of human annexin A2 receptor Features and Benefits Evaluate our antibodies with complete

General description Anti-APAF-1-ALT Antibody detects endogenous levels of total APAF-1-ALT protein. Immunogen The antiserum was produced against synthesized peptide derived from human APAF-1-ALT.

This antibody reacts with human APC2 by western blot and immunoprecipitation.  The antibody immunoprecipitates in vitro translated protein and protein from overexpressing cell lysates (using HeLa and NIH-3T3, and others).

Immunogen APC4 antibody was raised against a 14 amino acid peptide near the amino terminus of human APC4. Features and Benefits Evaluate our antibodies with complete peace of mind.

Immunogen Peptide with sequence C-EAASQNGEDLENLDD from the internal region (near the N Terminus) of the protein sequence according to NP_006780.1.

Anti-Aquaporin 2 Antibody is suitable for use in WB and IF microscopy. Expect a band approximately ~28.5kDa on specific lysates. May detect larger glycosylated bands ~35-50kDa. Specific conditions for reactivity should be optimized by the end user.

Immunogen Peptide with sequence CEQRRRTLLKDFHDT, from the C Terminus of the protein sequence according to NP_006312.1.